2026 ICD-10-CM Diagnosis Code D02.3Carcinoma in situ of other parts of respiratory system

ICD-10-CM CodesC00–D49D00-D09D02

ICD-10-CM D02.3
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D02.3 is a billable ICD-10-CM diagnosis code for carcinoma in situ of other parts of respiratory system. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 180 through 182. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Respiratory cancers.

Code Identity

ICD-10-CM Code
D02.3
Billable Status
Yes — Valid for Submission
Code Describes
Carcinoma in situ of other parts of respiratory system
Short Description
Carcinoma in situ of other parts of respiratory system
Same as the full description in the CMS dataset.
Parent Code
Carcinoma in situ of middle ear and respiratory system

Code Classification

ChapterC00–D49Neoplasms
SectionD00-D09In situ neoplasms
CategoryD02Carcinoma in situ of middle ear and respiratory system
This CodeD02.3Carcinoma in situ of other parts of respiratory system

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Carcinoma in situ of accessory sinus
  • Carcinoma in situ of ethmoidal sinus
  • Carcinoma in situ of eustachian tube
  • Carcinoma in situ of frontal sinus
  • Carcinoma in situ of mastoid air cells
  • Carcinoma in situ of maxillary sinus
  • Carcinoma in situ of middle ear
  • Carcinoma in situ of middle ear and mastoid
  • Carcinoma in situ of nasal cavity
  • Carcinoma in situ of nasal cavity and nasopharynx
  • Carcinoma in situ of nasopharynx
  • Carcinoma in situ of parietal pleura
  • Carcinoma in situ of pleura
  • Carcinoma in situ of sphenoidal sinus
  • Carcinoma in situ of tympanic antrum
  • Carcinoma in situ of tympanic cavity
  • Carcinoma in situ of vestibule of nose
  • Carcinoma in situ of visceral pleura
  • Mass of petrous part of temporal bone
  • Neoplasm of eustachian tube
  • Neoplasm of mastoid air cells
  • Neoplasm of mastoid antrum
  • Neoplasm of middle ear and mastoid
  • Neoplasm of nasal cavity and nasopharynx
  • Neoplasm of nasal vestibule
  • Neoplasm of parietal pleura
  • Neoplasm of visceral pleura

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Carcinoma in situ of accessory sinuses
  • Carcinoma in situ of middle ear
  • Carcinoma in situ of nasal cavities

Type 1 Excludes

  • carcinoma in situ of ear external skin D04.2
  • carcinoma in situ of nose NOS D09.8
  • carcinoma in situ of skin of nose D04.3

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO022
Respiratory cancers
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Eustachian Tube

    a narrow passageway that connects the upper part of the throat to the tympanic cavity.

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
antrum (Highmore) (maxillary)C31.0C78.39D02.3D14.0D38.5D49.1
antrum (Highmore) (maxillary) tympanicumC30.1C78.39D02.3D14.0D38.5D49.1
auditory canal (external) (skin) internalC30.1C78.39D02.3D14.0D38.5D49.1
auditory tubeC30.1C78.39D02.3D14.0D38.5D49.1
auricular canal (external) [See Also: Neoplasm, skin, ear] internalC30.1C78.39D02.3D14.0D38.5D49.2
cartilage (articular) (joint) NEC [See Also: Neoplasm, bone] nose, nasalC30.0C78.39D02.3D14.0D38.5D49.1
cavity nasalC30.0C78.39D02.3D14.0D38.5D49.1
cavity tympanicC30.1C78.39D02.3D14.0D38.5D49.1
concha [See Also: Neoplasm, skin, ear] noseC30.0C78.39D02.3D14.0D38.5D49.1
ear (external) [See Also: Neoplasm, skin, ear] innerC30.1C78.39D02.3D14.0D38.5D49.1
ear (external) [See Also: Neoplasm, skin, ear] middleC30.1C78.39D02.3D14.0D38.5D49.1
ethmoid (sinus)C31.1C78.39D02.3D14.0D38.5D49.1
eustachian tubeC30.1C78.39D02.3D14.0D38.5D49.1
frontal sinusC31.2C78.39D02.3D14.0D38.5D49.1
mastoid (air cells) (antrum) (cavity)C30.1C78.39D02.3D14.0D38.5D49.1
maxilla, maxillary (superior) antrumC31.0C78.39D02.3D14.0D38.5D49.1
maxilla, maxillary (superior) sinusC31.0C78.39D02.3D14.0D38.5D49.1
mucosa nasalC30.0C78.39D02.3D14.0D38.5D49.1
nares, naris (anterior) (posterior)C30.0C78.39D02.3D14.0D38.5D49.1
nose, nasal cartilageC30.0C78.39D02.3D14.0D38.5D49.1
nose, nasal cavityC30.0C78.39D02.3D14.0D38.5D49.1
nose, nasal fossaC30.0C78.39D02.3D14.0D38.5D49.1
nose, nasal internalC30.0C78.39D02.3D14.0D38.5D49.1
nose, nasal mucosaC30.0C78.39D02.3D14.0D38.5D49.1
nose, nasal septumC30.0C78.39D02.3D14.0D38.5D49.1
nose, nasal turbinate (mucosa)C30.0C78.39D02.3D14.0D38.5D49.1
nose, nasal vestibuleC30.0C78.39D02.3D14.0D38.5D49.1
nostrilC30.0C78.39D02.3D14.0D38.5D49.1
septumC30.0C78.39D02.3D14.0D38.5D49.1
septum nasalC30.0C78.39D02.3D14.0D38.5D49.1
sinus (accessory)C31.9C78.39D02.3D14.0D38.5D49.1
sinus (accessory) ethmoidalC31.1C78.39D02.3D14.0D38.5D49.1
sinus (accessory) frontalC31.2C78.39D02.3D14.0D38.5D49.1
sinus (accessory) maxillaryC31.0C78.39D02.3D14.0D38.5D49.1
sinus (accessory) nasal, paranasal NECC31.9C78.39D02.3D14.0D38.5D49.1
sinus (accessory) sphenoidC31.3C78.39D02.3D14.0D38.5D49.1
sphenoidC31.3C78.39D02.3D14.0D38.5D49.1
sphenoid sinusC31.3C78.39D02.3D14.0D38.5D49.1
turbinate (bone) nasalC30.0C78.39D02.3D14.0D38.5D49.1
tympanic cavityC30.1C78.39D02.3D14.0D38.5D49.1
vestibule noseC30.0C78.39D02.3D14.0D38.5D49.1

Patient EducationClinical

Cancer

Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.

The full article covers:

  • What is cancer?
  • What are the types of cancer?
  • How does cancer develop?
  • What are the symptoms of cancer?
  • How is cancer diagnosed?
  • What are the treatments for cancer?
  • Can cancer be prevented?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D02.3 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
231.8 Ca in situ resp sys NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D02.3Overview

Is D02.3 (Carcinoma in situ of middle ear and respiratory system) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report carcinoma in situ of other parts of respiratory system on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D02.3 group to?

When carcinoma in situ of other parts of respiratory system is the principal diagnosis on an inpatient stay, it groups to MS-DRG 180, 181, 182, with relative weights from 0.7440 to 1.7660 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D02.3?

Under the General Equivalence Mappings, carcinoma in situ of other parts of respiratory system converts to ICD-9-CM 231.8 (ca in situ resp sys NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.